LTRN Annual EBITDA
-$17.86 M
-$3.44 M-23.85%
31 December 2023
Summary:
As of January 23, 2025, LTRN annual earnings before interest, taxes, depreciation & amortization is -$17.86 million, with the most recent change of -$3.44 million (-23.85%) on December 31, 2023. During the last 3 years, it has fallen by -$11.96 million (-202.52%). LTRN annual EBITDA is now -934.70% below its all-time high of -$1.73 million, reached on December 31, 2018.LTRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN Quarterly EBITDA
-$5.18 M
+$229.00 K+4.24%
30 September 2024
Summary:
As of January 23, 2025, LTRN quarterly earnings before interest, taxes, depreciation & amortization is -$5.18 million, with the most recent change of +$229.00 thousand (+4.24%) on September 30, 2024. Over the past year, it has dropped by -$1.66 million (-47.03%). LTRN quarterly EBITDA is now -1040.67% below its all-time high of -$453.70 thousand, reached on March 31, 2019.LTRN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN TTM EBITDA
-$21.18 M
-$1.66 M-8.48%
30 September 2024
Summary:
As of January 23, 2025, LTRN TTM earnings before interest, taxes, depreciation & amortization is -$21.18 million, with the most recent change of -$1.66 million (-8.48%) on September 30, 2024. Over the past year, it has dropped by -$4.37 million (-25.98%). LTRN TTM EBITDA is now -4568.44% below its all-time high of -$453.70 thousand, reached on March 31, 2019.LTRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.9% | -47.0% | -26.0% |
| 3 y3 years | -202.5% | -24.8% | -76.9% |
| 5 y5 years | -934.7% | -673.3% | -772.9% |
LTRN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.9% | at low | -141.6% | +9.7% | -68.3% | at low |
| 5 y | 5-year | -636.1% | at low | -985.6% | +9.7% | -772.9% | at low |
| alltime | all time | -934.7% | at low | -1040.7% | +9.7% | -4568.4% | at low |
Lantern Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.18 M(-4.2%) | -$21.18 M(+8.5%) |
| June 2024 | - | -$5.40 M(-5.7%) | -$19.53 M(+1.1%) |
| Mar 2024 | - | -$5.73 M(+17.5%) | -$19.31 M(+8.1%) |
| Dec 2023 | -$17.86 M(+23.9%) | -$4.87 M(+38.5%) | -$17.86 M(+6.2%) |
| Sept 2023 | - | -$3.52 M(-32.1%) | -$16.81 M(+8.9%) |
| June 2023 | - | -$5.19 M(+21.1%) | -$15.44 M(+5.4%) |
| Mar 2023 | - | -$4.28 M(+12.0%) | -$14.64 M(+1.5%) |
| Dec 2022 | -$14.42 M(+14.6%) | -$3.82 M(+78.5%) | -$14.42 M(+2.2%) |
| Sept 2022 | - | -$2.14 M(-51.2%) | -$14.11 M(-12.4%) |
| June 2022 | - | -$4.39 M(+8.1%) | -$16.11 M(+13.5%) |
| Mar 2022 | - | -$4.06 M(+15.8%) | -$14.20 M(+12.8%) |
| Dec 2021 | -$12.58 M | -$3.51 M(-15.4%) | -$12.58 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$4.15 M(+67.4%) | -$11.97 M(+25.7%) |
| June 2021 | - | -$2.48 M(+1.1%) | -$9.52 M(+20.9%) |
| Mar 2021 | - | -$2.45 M(-15.3%) | -$7.88 M(+33.4%) |
| Dec 2020 | -$5.90 M(+143.3%) | -$2.89 M(+70.2%) | -$5.90 M(+60.3%) |
| Sept 2020 | - | -$1.70 M(+104.2%) | -$3.68 M(+38.9%) |
| June 2020 | - | -$832.80 K(+74.7%) | -$2.65 M(+8.3%) |
| Mar 2020 | - | -$476.70 K(-29.3%) | -$2.45 M(+0.9%) |
| Dec 2019 | -$2.43 M(+40.6%) | -$674.60 K(+0.8%) | -$2.43 M(+38.5%) |
| Sept 2019 | - | -$669.20 K(+6.4%) | -$1.75 M(+61.8%) |
| June 2019 | - | -$629.10 K(+38.7%) | -$1.08 M(+138.7%) |
| Mar 2019 | - | -$453.70 K | -$453.70 K |
| Dec 2018 | -$1.73 M | - | - |
FAQ
- What is Lantern Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Lantern Pharma?
- What is Lantern Pharma annual EBITDA year-on-year change?
- What is Lantern Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Lantern Pharma?
- What is Lantern Pharma quarterly EBITDA year-on-year change?
- What is Lantern Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Lantern Pharma?
- What is Lantern Pharma TTM EBITDA year-on-year change?
What is Lantern Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LTRN is -$17.86 M
What is the all time high annual EBITDA for Lantern Pharma?
Lantern Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.73 M
What is Lantern Pharma annual EBITDA year-on-year change?
Over the past year, LTRN annual earnings before interest, taxes, depreciation & amortization has changed by -$3.44 M (-23.85%)
What is Lantern Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LTRN is -$5.18 M
What is the all time high quarterly EBITDA for Lantern Pharma?
Lantern Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$453.70 K
What is Lantern Pharma quarterly EBITDA year-on-year change?
Over the past year, LTRN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.66 M (-47.03%)
What is Lantern Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LTRN is -$21.18 M
What is the all time high TTM EBITDA for Lantern Pharma?
Lantern Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$453.70 K
What is Lantern Pharma TTM EBITDA year-on-year change?
Over the past year, LTRN TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.37 M (-25.98%)